RAPT RAPT Therapeutics
- 2.921
- -0.129-4.23%
RAPT Therapeutics News
Should You Sell Your Stake in RAPT Therapeutics (RAPT)?
Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround
12 Health Care Stocks Moving In Monday's After-Market Session
GainersFibroGen (NASDAQ:FGEN) stock moved upwards by 24.4% to $1.53 during Monday's after-market session. The market value of their outstanding shares is at $152.1 million. Candel Therapeutics (NASDAQ
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Wolfe Downgrades RAPT, but Still Sees "Immense" Upside Potential
Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform
RAPT Therapeutics (RAPT) has an average rating of outperform and price targets ranging from $4 to $33, according to analysts polled by Capital IQ.
Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), RAPT Therapeutics (RAPT) and Hookipa Pharma (HOOK)
Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation
RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview
RAPT Falls for Second Day as Guggenheim, Barclays Downgrade Stock
Maintaining Hold Rating on RAPT Therapeutics Amid Clinical Uncertainties and Financial Outlook
Express News | RAPT Therapeutics Inc : Guggenheim Cuts to Neutral Rating
Express News | Guggenheim Downgrades RAPT Therapeutics to Neutral
RAPT Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 — Guggenheim Downgrades Buy → Neutral 04/10/2024 — HC Wainwright & Co. Reiterates → Neutral 0
Express News | RAPT Therapeutics Inc : Barclays Cuts to Equal Weight From Overweight; Cuts Target Price to $4 From $13
US Equity Markets Close Higher Thursday as Jobless Claims Climb
US equity markets ended higher Thursday as initial jobless claims increased more than expected. * Initial jobless claims rose by 22,000 to 231,000 in the week ended May 4 from an upwardly revised 209,
Sector Update: Health Care
Health care stocks rose late Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each gaining 0.8%. The iShares Biotechnology ETF (IBB) rose 0.7%. In c
RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials
RAPT Therapeutics (RAPT) shares plunged more than 40% in recent Thursday trading after the drugmaker reported a wider loss in Q1 and closed its clinical trials of zelnecirnon in atopic dermatitis and
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
On Thursday, RAPT Therapeutics Inc. (NASDAQ:RAPT) announced that it has decided to close and unblind both its Phase 2b trial of zelnecirnon (RPT193) in atopic dermatitis (AD) and its Phase 2a trial of
Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Duolingo, Inc. (NASDAQ:DUOL) fell sharply during Thursday's session after the company reported first quarter financial results.Duolingo reported quarterly earnings of 57 cents per share whic
Analysis
Price Target
No Data
